Definitive Contract W81XWH15C0080

Award Date 9/30/15
Potential Completion Date 2/28/19
Potential Value $1M
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Madison, WI 53719, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,730,436.20 firm-fixed price contract awarded by the U.S. Army Medical Command (MEDCOM) to Stratatech Corporation, a subsidiary of Mallinckrodt Plc, for a Phase 2 clinical trial to evaluate the safety and efficacy of an allogeneic skin substitute product called STRATAGRAFT. STRATAGRAFT contains both an epidermal and dermal layer and is intended for the treatment of complex, full-thickness skin injuries. The contract has an ultimate completion date of October 31, 2019 and was...
This is a federal contract award to the Medical Technology Enterprise Consortium (MTEC), a nonprofit organization, by the Defense Health Agency. The contract, valued at $57,747,970.25, is for a research project titled "Armed Forces Institute for Regenerative Medicine." It is an Other Transaction Order with an ultimate completion date of December 23, 2028. The contract is not set aside and will involve MTEC leveraging its consortium network to rapidly prototype and field innovative...
This federal contract award, W9114F16A0004|0013, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense to Musculoskeletal Transplant Foundation, Inc. (MTF Biologics), a non-profit organization. The contract is a Blanket Purchase Agreement (BPA) call for FY 2017 and has a firm fixed-price type with a ceiling value of $5,000,000.00. The contract is for the provision of medical tissue products and services, such as surgical implants, cartilage transplants, bone grafts, and...
This is a federal contract award to Geo-Med, LLC, a Service-Disabled Veteran-Owned Small Business (SDVOSB), for the delivery of Strattice Reconstructive Tissue Matrix medical supplies. The $3,573.90 fixed-price contract with economic price adjustment was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency, on February 21, 2025 with a completion date of April 8, 2025. The award is part of a larger $49,000,000 multiple-award Indefinite Delivery Contract (IDC)...
<p>This is a federal contract award from the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer. The contract, worth $121,473.00, is for the delivery of STRATTICE 20X30 products. The contract is a firm fixed price purchase order with a completion date of July 14, 2015. The contract does not have a set-aside designation.</p>
This is a firm fixed-price BPA call order issued by the Medical Command (MEDCOM) of the U.S. Department of Defense, with a ceiling value of $5,000,000.00. The contract was awarded to Musculoskeletal Transplant Foundation, Inc. (MTF Biologics), a non-profit organization that provides human tissue products and services for surgical procedures. The contract is for the delivery of goods and services in support of MEDCOM's FY17 requirements, with a period of performance ending on January 31, 2017....
This federal contract award, with ID W81XWH1590001|W81XWH2190007, was issued by the Defense Health Agency (DHA) to the Medical Technology Enterprise Consortium (MTEC), a nonprofit organization that serves as a medical technology accelerator for the Department of Defense. The contract is for multiple prototype projects resulting from the &quot;Prevention of Combat Wound Infections Request for Project Proposals (MTEC-21-03-WI)&quot;. The contract has a ceiling value of $15,542,372.31 and a...
This federal contract award W9114F16A0004|0011 was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense (DoD) to Musculoskeletal Transplant Foundation, Inc. (MTF Biologics), a non-profit organization that provides human tissue products for surgical procedures. The contract is a Blanket Purchase Agreement (BPA) Call, with a firm fixed-price structure, for FY16 calls 0001 through 0011 with a ceiling value of $5,000,000.00. The contract does not have a set-aside designation...
This federal contract award is for the delivery of BIOLOGICS - SYNTHETICS-MASTERGRAFT STRIP medical devices, valued at $6,720.30, by Medtronic Inc. through its Medtronic USA, Inc. division. The contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense, and does not have a set-aside designation. Medtronic is a global leader in medical technology, specializing in innovative medical devices and therapies. The company has a significant Indefinite Delivery...
This federal contract award was issued by the Defense Health Agency (DHA), an agency within the Department of Defense (DoD), to Medtronic Inc. through its Medtronic USA, Inc. division. The $2,274.30 fixed-price contract with economic price adjustment is for the delivery of BIOLOGICS - DBM-TS-GRAFTON DBF medical products, which are likely specialized surgical implants or biologics used in the treatment of military personnel and veterans. The contract does not have a set-aside designation and is...

This federal contract award, identified as W81XWH15C0080, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense (DOD) to Stratatech Corporation, a foreign-owned, for-profit company. The $999,957.14 cost-plus-fixed-fee contract was awarded on September 30, 2015 with a completion date of February 28, 2019. The contract was set aside for small businesses.

Stratatech Corporation is a subsidiary of Mallinckrodt Plc and has been registered in SAM.gov since 2005 to receive federal contract and grant awards. The company has previously received grant funding for the development of advanced regenerative medicine and tissue engineering products. This contract award appears to be related to Stratatech's work in these areas, though the specific products or services being delivered are not detailed in the information provided.

The contract is also associated with a larger Indefinite Delivery Vehicle (IDV) contract that Stratatech holds with the Department of Veterans Affairs (VA) to provide pharmaceuticals, drugs, and hematology-related products to VA medical facilities within the VA's Network 12 region. This multiple-award schedule contract has a potential value of $850,000 and runs through March 2027.

Generated 4/2/25, 4:50 PM